THE Therapeutic Goods Administration has released the four submissions that were made relating to the draft document Risk management plans for medicines and biologicals - Australian requirements and recommendations.
Submissions were received from Biotherapeutics Association of Australasia (BAA), Johnson & Johnson (J&J), Novartis Pharmaceuticals Australia and Pfizer Australia.
Visit tga.gov.au for submissions.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Feb 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Feb 17
